Filter Results:
(924)
Show Results For
- All HBS Web
(924)
- People (2)
- News (70)
- Research (773)
- Events (1)
- Multimedia (2)
- Faculty Publications (664)
Show Results For
- All HBS Web
(924)
- People (2)
- News (70)
- Research (773)
- Events (1)
- Multimedia (2)
- Faculty Publications (664)
- 01 Sep 2006
- News
Gift of Gab
then delivered a prepared talk on a topic of their choice. Subjects ranged from the pharmaceutical industry to the relative merits of cats vs. dogs, while Kim’s presentation took a humorous yet thoughtful... View Details
- Career Coach
Sarah Hoffner
industry as well as how to leverage career resources across HBS. She studied Public Health and History at Vanderbilt University and spent six years as a Client Service Lead at Entree Health, a pharmaceutical... View Details
- 22 Feb 2016
- Research & Ideas
The ‘Mother of Fair Trade’ was an Unabashed Price Protectionist
state pharmaceutical licensing exam, opened a drugstore with her husband in Stockton in 1915. Following his death, she became the sole proprietor and later opened two additional drugstores in town. Gleason emerged as a stalwart defender... View Details
- June 1999 (Revised June 2000)
- Case
Eckerd Corporation
By: Michael E. Porter and John E. Kelleher
Describes the history and current situation in the retail pharmacy industry, including competition from new merchants and Internet drugstores. Eckerd, one of the top four drug chains, must decide how to position itself for the future. View Details
Porter, Michael E., and John E. Kelleher. "Eckerd Corporation." Harvard Business School Case 799-141, June 1999. (Revised June 2000.)
- Fast Answer
Biotech, Medical Devices, and Pharmaceuticals: Industry/Market Overview/Analysis
Reports and market trends in spaces of biotech and pharmaceutical technologies and manufacturing-related fields. IBIS world - Market reports in spaces of biotech, pharmaceuticals, and medical devices in US, China, Australia, and UK... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical View Details
- Career Coach
Roshan Tathed
how these industries recruit, what the job experience will look like, and how they can help meet your personal criteria in a post-MBA career. He is happy to help with career visioning, companies shortlist, interview prep, resume and cover... View Details
- February 2002
- Case
Fighting AIDS and Pricing Drugs
In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant... View Details
Keywords: Developing Countries and Economies; Patents; Price; Strategy; Globalized Markets and Industries; Pharmaceutical Industry
Gourville, John T. "Fighting AIDS and Pricing Drugs." Harvard Business School Case 502-061, February 2002.
- 01 Dec 2004
- News
Finding a Balance
would otherwise be unable to afford treatment. Authored in 2003 by HBS professor Rohit Deshpandé, the case began as a straight pricing study. “The pharmaceutical industry is unlike any other,” Deshpandé... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 27 Jun 2005
- Research & Ideas
The Potential Downside of Win-Win
allowed even when it will impose costs on parties who are away from the table. The U.S. pharmaceutical industry is one of the great success stories of the past century. If View Details
Keywords: by Max H. Bazerman
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
division president, Health Care, Harris Interactive; and Sandra Feibelmann, a member of the Institute for Health Policy. Manda Salls: When did the pharmaceutical industry begin direct-to-consumer... View Details
Keywords: by Manda Salls
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
Association’s conference held on campus in early November. The three-day conference included presentations by industry executives, government officials, and HBS faculty on topics ranging from trends in the biotech and View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
challenges, not on the hard work of winning hearts and minds, Shapiro ultimately lost his company. He was forced to sell Monsanto to Pharmacia-Upjohn, which bought it for its pharmaceutical division, valuing the agricultural biotechnology... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- October 2000
- Case
Procter & Gamble Italy: The Pringles Launch (A)
By: Roy D. Shapiro
Procter & Gamble's (P&G) Pringles potato chips have been a very successful brand. This case reviews the development and first launch in the United States, then in markets around the world. Italy is one of the last countries where Pringles will be launched. Should P&G... View Details
Keywords: Globalized Markets and Industries; Brands and Branding; Marketing Strategy; Product Launch; Emerging Markets; Product Development; Adoption; Value Creation; Pharmaceutical Industry; United States
Shapiro, Roy D. "Procter & Gamble Italy: The Pringles Launch (A)." Harvard Business School Case 601-070, October 2000.
- Fast Answer
Investing in Life Sciences - SIP Resources
healthcare, pharmaceuticals and biotech industries including policy and science developments, and overview of different technologies. Factiva - Covers news from national and local newspapers, magazines,... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
don't survive clinical trials, resulting in the pharmaceutical industry footing enormous bills for failure. Genomics will be a productivity driver, pushing perhaps a 100 percent increase in drug development,... View Details
Keywords: by Sean Silverthorne
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
working on? A: I'm working on several cases right now, most of which deal with the pharmaceutical industry and the ways in which pharmaceutical firms manage through the... View Details
- 15 Dec 2024
- News
After Ozempic
health, which are promising but still speculative, each of these new applications would pile even more riches into the coffers of the nonprofit Novo Nordisk Foundation, which owns 28 percent of Novo Nordisk’s equity. The organizational structure is unusual for the... View Details